| |
Adis was established in the 1960s to publish independently evaluated information on new drug compounds. Today, the Adis brand represents total communications solutions for the pharmaceutical industry through peer-reviewed journals, decision-making tools, and customized medical communications solutions. When physicians, pharmacologists, and researchers worldwide seek independent, peer-reviewed coverage of drugs and drug development, chances are they find precisely what they're looking for in Adis journals and newsletters.
These highly regarded and frequently cited publications provide comprehensive and current information on all aspects of drug development, clinical pharmacology, biotechnology, pharmacoeconomics, and disease management. For thousands of readers worldwide, Adis journals and newsletters are trusted resources for the type of information that is rarely covered consistently in typical medical journals.
What does this mean for you?
From peer-reviewed original articles to insightful and expertly prepared reviews, Adis content enhances your understanding of therapeutic choices.
For more information about our journals, please visit www.adisonline.com |
